FDA has entered into a multi-year collaborative agreement with biotechnology company Emulate that will allow the agency to evaluate the potential uses of the company's Organs-on-Chips technology to monitor the simulated human organs' reactions to ingredients in food, cosmetic and supplement products. While the product is still in testing stages, an FDA spokesperson told Inside Health Policy they hope the product will one day be used for regulatory decision-making -- though the spokesperson declined to say whether FDA would...